1,101
Views
20
CrossRef citations to date
0
Altmetric
Short Communication

Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity

, , , , , , & ORCID Icon show all
Pages 665-671 | Received 27 Jan 2020, Accepted 19 Feb 2020, Published online: 05 Mar 2020

References

  • Stewart TJ, Abrams SI. How tumours escape mass destruction. Oncogene 2008;27:5894–903.
  • Schwartz L, Supuran CT, Alfarouk KO. The Warburg effect and the hallmarks of cancer. Anti-Cancer Agents Med Chem 2017;17:164–70.
  • Supuran CT. Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites 2017;7:48.
  • Krasavin M, Shetnev A, Sharonova T, et al. Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms. Bioorg Chem 2018;76:88–97.
  • Krasavin M, Shetnev A, Sharonova T, et al. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. Eur J Med Chem 2019;164:92–105.
  • Bakulina O, Bannykh A, Jovanović M, et al. Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols. J Enzyme Inhib Med Chem 2019;34:665–71.
  • Arner ES, Holmgren A. The thioredoxin system in cancer. Semin Cancer Biol 2006;16:420–6.
  • Zhang J, Li X, Han X, et al. Targeting the thioredoxin system for cancer therapy. Trends Pharmacol Sci 2017;38:794–808.
  • Bian M, Fan R, Zhao S, Liu W. Targeting the thioredoxin system as a strategy for cancer therapy. J Med Chem 2019;62:7309–21.
  • Zhang B, Zhang J, Peng S, et al. Thioredoxin reductase inhibitors: a patent review. Exp Opin Ther Pat 2017;27:547–56.
  • Saccoccia F, Angelucci F, Boumis G, et al. Thioredoxin reductase and its inhibitors. Curr Protein Pept Sci 2014;15:621–46.
  • Jovanović M, Zhukovsky D, Podolski-Renić A, et al. Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: identification of DVD-445 as a new lead compound for anticancer therapy. Eur J Med Chem 2019;181:111580.
  • Copeland PR. Making sense of nonsense: the evolution of selenocysteine usage in proteins. Genome Biol 2005;6:221.
  • Kelly M, Kincaid J, Janagani S. 2-substituted and 4-substituted aryl nitrone compounds. US Patent Application No US20050182060A1, 2005.
  • Hubina AV, Pogodaev AA, Sharoyko VV, et al. Self-assembled spin-labeled nanoparticles based on poly(amino acids). React Funct Polym 2016;100:173–80.